bipolar disorder

Bipolar disorder affects approximately 40–50 million people globally and is associated with significant functional impairment, comorbidity, and excess mortality. Long-term mood stabilisation with lithium, valproate, or atypical antipsychotics forms the backbone of maintenance therapy. Precision psychiatry approaches and novel targets including inflammation and circadian rhythm dysregulation are under active investigation.